The pharmaceutical industry operates within one of the most highly regulated and technically demanding environments in the world. Every decision must balance competing priorities: delivering medicines rapidly while maintaining uncompromising quality, embracing technological innovation while complying with complex regulations, improving manufacturing efficiency while protecting patient safety, and accelerating scientific progress without compromising validation or data integrity.
These contradictions are encountered daily by manufacturing, quality assurance, validation, IT, clinical, and supply chain teams across pharmaceutical organizations. Pharma TRIZ offers a structured alternative to accepting these tensions as unavoidable trade-offs. Applying the Theory of Inventive Problem Solving (TRIZ) to pharmaceutical operations, this original methodology combines systematic contradiction resolution with the realities of modern manufacturing, quality systems, validation, computerized systems, laboratories, clinical operations, and enterprise governance.
Rather than assuming that stronger compliance must reduce agility or that better quality must increase cost, the book shows how to identify the true conflict behind an operational challenge and design solutions that improve multiple objectives at the same time. Covering Good Manufacturing Practice compliance, computerized system validation, quality assurance, cybersecurity, clinical operations, and supply chain management, the book gives pharmaceutical professionals a repeatable framework for resolving conflicts that have traditionally been managed through compromise.
It is designed to complement, not replace, established regulatory frameworks such as GMP, GAMP 5, FDA 21 CFR Part 11, EU GMP Annex 11, and ICH guidelines, providing an additional decision-making methodology grounded in real operational challenges rather than abstract theory. Written by Willy Danenberg, an independent consultant and executive advisor specializing in IT governance, cybersecurity, digital transformation, risk management, and organizational leadership, this book is designed for quality assurance professionals, validation specialists, manufacturing leaders, regulatory affairs teams, and pharmaceutical executives who need practical tools for resolving operational conflicts while maintaining the highest standards of product quality, patient safety, and regulatory compliance.
The pharmaceutical industry operates within one of the most highly regulated and technically demanding environments in the world. Every decision must balance competing priorities: delivering medicines rapidly while maintaining uncompromising quality, embracing technological innovation while complying with complex regulations, improving manufacturing efficiency while protecting patient safety, and accelerating scientific progress without compromising validation or data integrity.
These contradictions are encountered daily by manufacturing, quality assurance, validation, IT, clinical, and supply chain teams across pharmaceutical organizations. Pharma TRIZ offers a structured alternative to accepting these tensions as unavoidable trade-offs. Applying the Theory of Inventive Problem Solving (TRIZ) to pharmaceutical operations, this original methodology combines systematic contradiction resolution with the realities of modern manufacturing, quality systems, validation, computerized systems, laboratories, clinical operations, and enterprise governance.
Rather than assuming that stronger compliance must reduce agility or that better quality must increase cost, the book shows how to identify the true conflict behind an operational challenge and design solutions that improve multiple objectives at the same time. Covering Good Manufacturing Practice compliance, computerized system validation, quality assurance, cybersecurity, clinical operations, and supply chain management, the book gives pharmaceutical professionals a repeatable framework for resolving conflicts that have traditionally been managed through compromise.
It is designed to complement, not replace, established regulatory frameworks such as GMP, GAMP 5, FDA 21 CFR Part 11, EU GMP Annex 11, and ICH guidelines, providing an additional decision-making methodology grounded in real operational challenges rather than abstract theory. Written by Willy Danenberg, an independent consultant and executive advisor specializing in IT governance, cybersecurity, digital transformation, risk management, and organizational leadership, this book is designed for quality assurance professionals, validation specialists, manufacturing leaders, regulatory affairs teams, and pharmaceutical executives who need practical tools for resolving operational conflicts while maintaining the highest standards of product quality, patient safety, and regulatory compliance.
